Overview
Samuel Meignan practices in Lille, France. Mr. Meignan is rated as an Advanced expert by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. His top areas of expertise are Diffuse Midline Glioma H3 K27M-Mutant, Glioma, Gliomatosis Cerebri, and Brain Tumor.
His clinical research consists of co-authoring 31 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 4 articles in the study of Diffuse Midline Glioma H3 K27M-Mutant.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Diffuse Midline Glioma H3 K27M-Mutant
- GliomaMr. Meignan isAdvanced. Learn about Glioma.
- Experienced
- Brain Stem CancerMr. Meignan isExperienced. Learn about Brain Stem Cancer.
- Brain TumorMr. Meignan isExperienced. Learn about Brain Tumor.
- Breast CancerMr. Meignan isExperienced. Learn about Breast Cancer.
- Cerebral HypoxiaMr. Meignan isExperienced. Learn about Cerebral Hypoxia.
- Gliomatosis CerebriMr. Meignan isExperienced. Learn about Gliomatosis Cerebri.
- Triple-Negative Breast CancerMr. Meignan isExperienced. Learn about Triple-Negative Breast Cancer.